No abstract available.
Constriction, Pathologic*

No abstract available.
Dilatation, Pathologic*

No abstract available.
Aortic Aneurysm, Abdominal* ; Pulmonary Embolism* ; Venous Thrombosis*

No abstract available.
Pneumonectomy*

No abstract available.
Histiocytoma, Benign Fibrous* ; Pulmonary Sclerosing Hemangioma*

No abstract available.
Bronchi* ; Bronchogenic Cyst* ; Trachea*

No abstract available.
Fistula*

Perfluorocarbon liquids have been shown to be a useful intraoperative adjunct in managing complicated retinal detachment. To prove the effectiveness of intraoperative use of perfluorocarbon liquid and the improvement of surgical and functional outcomes, we retrospcetively evaluated the clinical results of the patients[13 eyes]who had retinal detachment complicated with proliferative vitreoretinopathy [over PVR Grade C4, C4 :7 eyes, C5 :6 eyes]. We performed standard 3-port pars plana vitrectomy in all eyes included in this study.Perfluorodecalin[DK-line]was used as a shortterm vitreous substitute intraoperatively and removed before the end of the surgery. The mean follow-up period was 15 months.Anatomical success rate was 86%[6 eyes]in Grade C4, 67%[4 eyes]in Grade C5, Visual acuity was over 5/200 in one eye[8%]and there was improvement in 5 eyes[40%] although it was below 5/200. Consequently, we could easily manage the retinal detachment with PVR with help of intraoperative perfluorocarbon liquid and could improve the postoperative surgical and visual outcomes.
Follow-Up Studies ; Retinal Detachment ; Visual Acuity ; Vitrectomy ; Vitreoretinopathy, Proliferative*

BACKGROUND: External ventricular drainage (EVD) is an important procedure for draining excessive cerebrospinal fluid (CSF) and monitoring intracranial pressure. Generally, EVD is performed in the operating room (OR) under aseptic conditions. However, in emergency circumstances, the operation may be performed in the intensive care unit (ICU) to save neuro-critical time and to avoid the unnecessary transfer of patients. In this study, we retrospectively analyzed the risk of EVD-induced CNS infections and their outcomes according to the operating place (ICU versus OR). In addition, we compared mortalities as well as hospital and ICU days between the CNS infection and non-CNS infection groups. METHODS: We reviewed medical records, laboratory data and radiographic images of patients who had received EVD operations between January, 2013 and March, 2015. RESULTS: A total of 75 patients (45 men and 30 women, mean age: 58.7 +/- 15.6 years) were enrolled in this study. An average of 1.4 catheters were used for each patient and the mean period of the indwelling catheter was 7.5 +/- 5.0 days. Twenty-six patients were included in the ICU group, and EVD-induced CNS infection had occurred in 3 (11.5%) patients. For the OR group, forty-nine patients were included and EVD-induced CNS infection had occurred in 7 (14.3%) patients. The EVD-induced CNS infection of the ICU group did not increase above that of the OR group. The ICU days and mortality rate were higher in the CNS infection group compared to the non-CNS infection group. The period of the indwelling EVD catheter and the number of inserted EVD catheters were both higher in the CNS infection group. CONCLUSIONS: If the aseptic protocols and barrier precautions are strictly kept, EVD in the ICU does not have a higher risk of CNS infections compared to the OR. In addition, EVD in the ICU can decrease the hospital and ICU days by saving neuro-critical time and avoiding the unnecessary transfer of patients. Therefore, when neurosurgeons decide upon the operating place for EVD, they should consider the benefits of ICU operation and be cautious of EVD-induced CNS infection.
Catheter-Related Infections ; Catheters ; Catheters, Indwelling ; Cerebrospinal Fluid ; Drainage* ; Emergencies ; Female ; Humans ; Intensive Care Units* ; Critical Care* ; Intracranial Pressure ; Male ; Medical Records ; Mortality ; Operating Rooms* ; Retrospective Studies ; Ventriculostomy

PURPOSE: Several sets of criteria have been proposed and used by different authors, but the patients with Sjoren's syndrome have been missed at diagnosis or incorrectly classified due both to its great variability at presentation and to the lack of commonly accepted diagnostic criteria. We proposed a criteria for Sjoren's syndrome and attempted to utilize this criteria for diagnosis and classification of dry eye patients who were suspected of Sjoren's syndrome. METHODS: We proposed and applied a set of criteria for Sjoren's syndrome, which included clinical, histopathological and laboratory features as well as exclusions for the diagnosis, to 6 dry eye patients who were clinically at Chungnam National University Hospital from January 1992 to December 1996. RESULTS: Two of the 6 patients who were clinically suspected of Sjoren's syndrome had satisfactory histopathological results. This two patients were diagnosed as primary Sjoren's syndrome. CONCLUSIONS: Our criteria would be helpful to the diagnosis and classification of the patients with Sjoren's syndrome, who were previously diagnosed as dry eye syndrome.
Chungcheongnam-do ; Classification ; Diagnosis ; Dry Eye Syndromes ; Humans